When treatment itself causes harm: an important message for people with aspergillosis

For most people, following medical advice is the safest and most appropriate course of action. However, for some people living with aspergillosis or other long-term lung conditions, treatment itself can occasionally cause harm — particularly when adverse drug reactions are not recognised early.

Aspergillosis often requires long-term or repeated courses of medication, sometimes alongside treatment for co-existing infections or other conditions. Because symptoms of aspergillosis can overlap with medication side effects, new or worsening problems may be assumed to be part of the illness rather than a reaction to treatment.

Why this can be difficult to recognise

People with aspergillosis may:

• already experience fatigue, breathlessness, pain, or neurological symptoms

• take multiple medicines at the same time

• have fluctuating symptoms due to infection, inflammation, or treatment response

This makes it harder to distinguish disease activity from drug-related effects.

The importance of recognising adverse drug reactions

Some medicines commonly used in people with lung disease can, in a small number of individuals, cause serious or long-lasting side effects. These reactions may develop gradually or worsen with continued use.

Examples (not exhaustive) include:

• Antibiotics – tendon, nerve, gastrointestinal, cardiac or immune-related effects

• Antifungal medicines – liver toxicity, neurological symptoms, skin reactions, drug interactions

• Steroids – bone loss, adrenal suppression, mood changes, infection risk

• Immunosuppressive or biologic therapies – infection risk, immune dysregulation, inflammatory reactions

Not everyone experiences these effects, and many people take these medicines safely. However, when significant new symptoms appear after starting or changing treatment, they should be actively reassessed.

Why knowledge of medication side effects matters

Patients are not expected to diagnose themselves. However, having a basic awareness of known serious side effects can help patients recognise when something may not be right.

In the UK, trusted sources such as the British National Formulary (BNF) list both common and rare but serious adverse effects for prescribed medicines, and drug:drug interactions which are particularly significant for antifungal medications. Reviewing this information can support informed discussions with healthcare professionals, particularly if symptoms worsen rather than improve.

Checking authoritative sources is not about challenging clinical expertise or stopping treatment independently. It is about ensuring that potential drug reactions are considered alongside disease progression.

A balanced message for patients and clinicians

Safe care depends on partnership. This means:

• patients feeling able to report side effects clearly and repeatedly if needed

• clinicians remaining alert to drug reactions, especially when symptoms are atypical or progressive

• being willing to pause, review, and reconsider treatment when outcomes are not as expected

Early recognition of adverse drug reactions can reduce the risk of long-term or permanent harm.

Take-home message

If treatment is making you feel significantly worse, and the symptoms do not feel right for you, it is reasonable to ask for reassessment — even if the treatment is commonly used or usually well tolerated.

Being informed, listened to, and reviewed promptly helps ensure safer care for people living with aspergillosis.